in the regulation of the vascular tone (3) .
Uridine 5′-triphosphate (UTP) also mediates signaling from the extracellular side to the cell interior. UTP can be released from a variety of cells including platelets, endothelial cells, epithelial cells (e.g., airway and intestinal epithelial cells), and neural cells (e.g., C6 glioma cells and primary astrocytes) (4) . In the cardiovascular system, the main source of UTP is endothelial cells from which it is released in response to hypoxia and inflammation (3) . UTP is released to the luminal side of blood vessels and thus has a limited access to intact vascular smooth muscle. However, the accessibility may dramatically increase when endothelial integrity is disrupted, for example, arterial ruptures (hemorrhage) or disease state (stroke and atherosclerosis) (5 -7) .
Nucleotide receptors are classified into two groups, that is, ionotropic P2X receptors and metabotropic P2Y receptors coupled to guanosine 5′-triphosphate binding protein (G-protein) and downstream effectors. UTP has been recognized as a specific agonist for P2Y receptors (but not for P2X receptors) capable of producing vasoconstriction through intracellular Ca 2+ release from the sarcoplasmic reticulum via activation of the P2Y 2 , P2Y 4 , and/or P2Y 6 receptor(s) / G q/11 / inositol 1,4,5-triphosphate (IP 3 ) receptor cascade (3, 8) . However, several recent studies have shown that UTP can also induce a non-selective cation current, thereby depolarizing the membrane that in turn promotes Ca 2+ influx through dihydropyridine-sensitive voltage-dependent Ca 2+ channels (L-type VDCCs) and cause vasoconstriction (9) . The induction of this cation current has been proposed to involve the activation of TRPC3 via phospholipase C (PLC)-linked P2Y 2 , P2Y 4 , and/or P2Y 6 receptor(s) and subsequent generation of IP 3 and diacylglycerol (10) . In the same study, the current-voltage (I-V) relationship of UTP-induced cation current has been found to display inward-going rectification. However, this property does not match up with the reported outward-rectification of TRPC3-mediated current (11) , but is rather similar to that of the P2X receptor-mediated current (12) . This inconsistency prompted us to re-examine the nature of receptors involved in the actions of UTP especially with respect to P2X as well as P2Y receptors. To this end, we employed several functional techniques, that is, patch clamping, intracellular Ca 2+ imaging, and tension recording techniques, combined with reverse transcriptasepolymerase chain reaction (RT-PCR), Western blotting, and immunostaining of cells and tissues. Our data suggest that UTP exerts dual effects on the contractility of rat arteries via activation of both ionotropic and metabotropic P2 receptors (i.e., P2X 1 -like receptor together with P2Y receptors).
Materials and Methods

Tissue and cell preparation
Male Sprague-Dawley rats (10 -11-week-old) were anesthetized by inhalation of diethylether and euthanized by decapitation. Arterial tissues (aorta, cerebral, and mesenteric arteries) were removed and placed in cold (4°C) physiological salt solution (PSS). For tension recording, aorta rings were placed in warmed (37°C) Krebs solution equilibrated with 5% CO 2 and 95% O 2 . To obtain the cell preparation, arterial segments were enzymatically digested by incubating (37°C) them sequentially in low Ca 2+ (0.5 mM) PSS containing papain (0.5 mg/mL), followed by 1 mM Ca 2+ PSS containing type 2 collagenase (2 mg/mL; Worthington, Lakewood, NJ, USA). Digested arterial segments were transferred to PSS containing 1.5 mM Ca 2+ , stored on ice, and used within 3 h. All animal experiments followed the guideline of the Local Animal Ethics Committee of Kyushu University.
Patch clamp recording
Whole-cell (voltage or current clamp) and single channel recordings were performed by using an Axopatch-1D patch clamp amplifier (Axon Instruments, Foster City, CA, USA) driven by an IBM compatible computer with pClamp v6.04 software (Axon Instruments). In detail, a TL-1 A/D, D/A board was used to generate and apply voltage pulses to clamped cells and to sample corresponding membrane currents. Current signals were lowpass filtered at 1 kHz and digitized at 5 kHz before being stored on a computer hard disk. Data were analyzed by Clampfit v.8.2, (Axon Instruments) after being filtered at 300 Hz with a Gaussian and an 8-pole Bessel filter, for whole cell and single channel recordings, respectively. For continuous recording, data were recorded and analyzed by the PowerLab/4SP system using Chart 5 software. Data analysis and illustration of the results were made by pClamp v8.1, Corel draw v11.0 (Corel Corporation, Ontario, Canada), and Kaleidagraph v3.04 (Synergy Software, Reading, PA, USA). All experiments were performed at room temperature (22°C -25°C).
Tension development
Aortae were cleaned of fat and connective tissues with a fine micro-scissors and forceps and cut into short rings (5 -7 mm in length, 1 mm in width). The ring preparation was denuded of endothelium by tenderly rubbing with a wet, thin, twisted strip of tissue paper. Lack of endothelium-dependent relaxation to acetylcholine (10 μM) was confirmed in rings pre-contracted with phenylephrine (1 μM) prior to further experiments. Tension (T) of vessels was normalized by the following formula: T N = (T − T 0 ) / (L × IC), in which T N is the normalized force (g), T 0 is the initial tension (g), L is the tissue wall length (mm), and IC is the internal circumference (mm, calculated after applying the initial tension). Data were recorded and analyzed by the PowerLab/8SP system on Chart 5 software and MLT050/D force transducer (AD Instruments Pty., Ltd., Bella Vista, NSW, Australia). The solution was pre-warmed at 37°C and propelled by a Minipuls 3 peristaltic pump (Gilson, Inc., Middleton, WI, USA). The flow rate was 3 mL/min.
Measurement of intracellular calcium
Cells were loaded with 2.5 μM fura-2/acetoxymethylester on ice for 30 min. Then they were plated on gelatincoated, glass-bottom, 35-mm dishes for 5 min at room temperature (22°C -25°C). The 100-μL external solution was replaced 2 min before the experiment. Concentrated UTP (10 mM, adjusted pH at 7.4) was dropped into the solution directly in the center of dish. The fluorescence intensity of fura-2 was measured at an excitation wavelength of 340 and 380 nm with a video image analysis system (Aquacosmos; Hamamatsu Photonics, Hamamatsu). Emission was collected at 510 nm and the ratio (R = F340/F380) of fura-2 fluorescence intensities was used as an index of the intracellular Ca 2+ concentration (13) .
RT-PCR analysis
Total RNA was extracted from whole rat brain and arterial tissues with Trizol reagent (Invitrogen, Carlsbad, CA, USA). After DNase treatment (DNA-free kit; Applied Biosystems, Foster City, CA, USA), total RNA (4 μg) was subjected to reverse transcription using Super Script III reverse transcriptase (Invitrogen), and a 100-ng sample of the RT products was used for each PCR amplification. The PCR protocol included preheating the sample at 94°C for 1 min followed by 30 cycles consisting of denaturation at 94°C for 10 s, annealing at 64°C for 30 s, and extension at 72°C for 1 min, and final extension at 72°C for 10 min. PCR high fidelity supermix (Invitrogen) enzyme was used for all PCR reactions. The following oligonucleotide primer pairs specific for the respective gene isoforms were used: Rat P2Y 2 (GI: 38197685): forward, TTCCACGTCACCCGCACCCTC TTATTACT and reverse, CGATTCCCCAACTCACA CATACAAATGATTG (product length: 539 bp); rat P2Y 4 (GI: 13928943): forward, CTTCTCTGCCTGGG TGTTTGGTTGGTAGTA and reverse, TCCCCCGTGA AGAGATAGAGCACTGGA (473 bp); rat P2Y 6 (GI: 48675856): forward, GCCAGTTATGGAGCGGGACA ATGG and reverse, AGGAACAGGATGCTGCCGTG TAGGTTG (357 bp).
Western blot analysis
Tissues (rat brain, cerebral and mesenteric arteries, and aorta) were homogenized in 1 mL ice-cold buffer (50 mM HEPES buffer at pH 7.4, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 50 mM sodium fluoride, 40 mM sodium β-glycerophosphate, 2 mM sodium orthovanadate, 30 mM sodium pyrophosphate, and protease inhibitors cocktail containing 5 μg/mL pepstatin A, 10 μM leupeptin, 1.7 μg/mL aprotinin, and 50 μM 4-amidinophenylmethanesulfonyl fluoride); then the homogenate was centrifuged at 50,000 × g for 30 min at 4°C. The supernatants (20 μg) were separated on 10% SDS-polyacrylamide gels and transferred to polyvinyldifluoride membrane. Immunoblot analysis was performed using antibodies against P2X 1 receptor (anti-rabbit, 1:500; Alomone, Jerusalem, Israel) and TRPC3 (anti-rabbit, 1:500; Alomone). Anti-mouse β-actin antibody (1:1000; Cell Signaling Technology, Inc., Beverly, MA, USA) was used for the positive control, and P2X 1 receptor antibody (1:500) pre-incubated with specific antigen peptide (1:500) was used for the negative control. Blots were developed with horseradish peroxidase-coupled secondary antibodies and visualized using the electrochemiluminescence (ECL) system (GE Healthcare UK Ltd., Buckinghamshire, UK).
Immunohistochemistry
Rat aorta samples were fixed with 4% paraformaldehyde (PFA) in a phosphate-buffered saline (PBS, pH = 7.4) overnight, embedded in paraffin, and sectioned at 7-μm thickness. Individual sections were deparaffined by treatment with xylene, followed by a stepwise rehydration process with graded ethanol solutions. Samples were incubated in blocking buffer [2.5% bovine serum albumin (BSA) in PBS] for 1 h and then incubated with the first antibodies: anti-rabbit P2X 1 For cell staining, enzymatically isolated rat aortic smooth muscle cells were dropped on coverslips, bathed in 1 mL low Ca 2+ (100 μM) PSS, and incubated at 4°C for 30 min. Then cells were fixed with direct addition of 1 mL of 10% PFA in PBS (pH = 7.4) and incubated at 4°C for 5 min. Cells were rinsed with PBS and fixed again with 4% PFA in PBS for 5 min at room temperature. After fixation, the cells were permeabilized with 50 μg/mL digitonin for 5 min, subsequently quenched with 50 μM NH 4 Cl for 5 min, and incubated in blocking buffer for 1 h. Samples were incubated with the first antibodies as described above, followed by incubation with the secondary antibody. Finally, samples were mounted with Mountant, PermaFlour (Lab Vision Products, Thermo Fisher Scientific) for visualization. Both tissue and single cell samples were visualized at appropriate wavelengths by a confocal microscope (LSM 510 META; Carl Zeiss Microimaging GmbH, Jena, Germany). The images were processed using Adobe Photoshop 5.5 (Adobe Systems Inc., San Jose, CA, USA).
Solutions and drugs
The internal (pipette) solution for whole-cell and single channel patch-clamp experiment contained 140 mM CsCl, 1.5 mM MgCl 2 , 10 mM N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic acid (HEPES), 10 mM glucose, 10 mM ethylene glycol-bis (2-aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA) (pH = 7.2, adjusted by Tris), and the external (bath) solution contained 140 mM NaCl, 1.5 mM MgCl 2 , 2 mM CaCl 2 , 10 mM HEPES, and 10 mM glucose (pH = 7.4, Tris). In some experiments, 140 mM CsCl was replaced with 110 mM Cs-aspartate and 30 mM CsCl for the pipette solution, and 140 mM N-methyl-D-glucamine (NMDG) substituted for 140 mM Na + in the external solution. For the current clamp recording, the internal solution was changed to the following: 140 mM KCl, 1.5 mM MgCl 2 , 10 mM HEPES, 10 mM glucose, and 1 mM EGTA (pH = 7.4, Tris). Chemicals were applied by the 'Y-tube' fast solution change device described of Morita et al (14) . Modified Krebs solution, warmed to 37°C for tension recording, contained 121.9 mM NaCl, 4.7 mM KCl, 1.2 mM MgCl 2 , 2.5 mM CaCl 2 , 15.5 mM NaHCO 3 , 1.2 mM KH 2 PO 4 , and 11.5 mM glucose (pH = 7.4) continuously aerated with 97% O 2 and 3% CO 2 . All chemicals were obtained from Sigma-Aldrich (St. Louis, MO, USA), except for uridine 5′-O-3′-thiotriphosphate (UTPγS), which was purchased from Jena Bioscience (Jena, Germany). All solutions containing purines and pyrimidines were used after adjusting the pH to 7.4.
Statistics
All data are expressed as the mean ± standard error (S.E.M.). A two-tailed unpaired Student's t-test and oneway ANOVA were used for statistical evaluation.
Results
UTP activates a non-selective cation current in rat arterial myocytes
When increasing concentrations of UTP (1 -100 μM) were applied to single rat aortic myocytes, inward currents were induced in a concentration-dependent manner at the holding potential of −60 mV, near the resting potential of arterial smooth muscle cells (7) . UTP activated the current almost immediately after its application, which exhibited, at high concentrations of UTP (≥100 μM), a rapid desensitizing decay (Fig. 1Aa) . The time constants for activation and desensitization became progressively shorter as the concentration of UTP was increased, and the current did not recover from the desensitization (Supplementary Fig. 1 : available in the online version only). In current clamp mode, UTP (10 μM -1 mM) produced concentration-dependent membrane depolarization (up to 0 mV from −60 mV with 140 mM K + containing internal solution, Supplementary Fig. 2 : available in the online version only), well above the activation threshold for VDCCs (>−40 mV from −70 mV) (15) . Furthermore, UTP-induced depolarization was also induced by suppression of ATP-sensitive K + and voltageactivated K + channels (9, 16) , thereby contributing to the generation of sustained membrane depolarization.
The current-voltage relationship of the UTP-induced current showed an inward-going rectification (Fig. 1Ab) . The reversal potential of UTP-induced current was 9.1 ± 1.3 mV (n = 7) and remained unchanged (9.4 ± 1.9 mV, n = 5) when the concentration of Cl − in the pipette solution was reduced from 143 to 33 mM with aspartate substitution (equilibrium potentials of Cl − calculated according to Nernst's equation were −1.6 and −39.2 mV at 25.0°C for 143 and 33 mM Cl − , respectively). Moreover, substitution of Na + with NMDG in the bath almost completely abolished the current (in the presence and absence of 2 mM Ca 2+ : 93.7 ± 1.8% and 100% inhibition, respectively, n = 5). In addition, a potent L-type calcium channel inhibitor, nifedipine (10 μM), was completely ineffective on the current (100.0 ± 2.3%, n = 5). These results clearly indicate that UTP activates a nonselective cationic current with rapid activating and desensitizing properties. This is strongly reminiscent of P2X receptor as has been reported for rat tail artery smooth muscle cell (17) .
Consistent with this idea, similar rapidly activating and desensitizing currents with inward-rectifying property were also induced by a potent P2X 1 -receptor agonist, α,β-methylene ATP (right panel in Fig. 1Aa and closed circles in Supplementary Fig. 1A ). The concentrationresponse relationships fitted by the Hill equation indicate that the half maximal effective concentration (EC 50 ) value for α,β-methylene ATP (0.55 μM) to induce the inward current is much lower than that for UTP (1.2 mM) (Fig. 1B) , suggesting that the former is a more potent agonist.
UTP as well as α,β-methylene ATP could also induce cation currents with fast kinetics in cerebral and mesenteric artery smooth muscle cells ( Supplementary Fig. 3A : available in the online version only). Although the maximum current density of the UTP-current was variable for three distinct arterial myocytes (20.1 ± 0.6, 20.7 ± 3.8, and 2.4 ± 0.2 pA/pF at −60 mV for aortic, mesenteric, and cerebral artery myocytes, respectively, n = 3 -10). Its concentration-dependence was similar when standardized by the maximum amplitude attained by 10 μM α,β-methylene ATP (Fig. 1C) .
The induction of inward current by α,β-methylene ATP in aortic myocytes was greatly reduced by preceding desensitization with UTP, and vice versa, suggesting that the actions of both agonists desensitized each other ( Fig. 2A) . Furthermore, cumulative application of UTP at concentrations over 1 mM also showed desensitization of the current (Supplementary Fig. 3B ). In contrast, other uridine derivatives such as uridine 5′-diphosphate (UDP), uridine 5′-monophosphate (UMP), and uridine exhibited only a weak or little efficacy in inducing the inward current; UDP induced an inward cationic current at concentration as high as 1 mM (filled triangles in Fig. 1B) , and UMP (1 mM) and uridine (1 mM) were totally ineffective. We also used UTPγS, a stable UTP analog, to exclude the effect of possible contamination by ATP or other ATP analogs of UTP or UDP (18) . UTPγS (>10 μM) activated the inward current (data not shown). These results in aggregate support the view that UTP induces the cationic current via activation of P2X receptor(s).
To observe the maximum effect of UTP, a high concentration of UTP (1 mM) was used in following experiments.
UTP activated P2X 1 -like receptor in aortic myocytes
To further confirm that induction of rapidly desensitizing cationic currents by UTP is mediated via P2X-receptor activation, we next examined the effects of nonspecific P2-receptor antagonists, suramin and pyridoxal phosphate-6-azo(benzene-2,4-disulfonic acid) (PPADS), and a P2X receptor-selective antagonist, 2′,3′-O-(2,4,6- (19, 20) . As illustrated in Fig. 2B , the half maximal inhibitory concentration (IC 50 ) and the cooperativity coefficient estimated by Hill analysis were, respectively, 0.43 μM and 1.3 for suramin, 0.59 μM and 1.1 for PPADS, and 0.95 μM and 0.9 for TNP-ATP (n = 3 -5). Interestingly, a low concentration of suramin (100 nM) potentiated the UTP-induced current (141.1 ± 1.3%, n = 3) (Fig. 2B) , similar to the effect of suramin (300 nM) on α,β-methylene ATP (3 μM)-induced P2X 1 receptor-like current in rat mesenteric artery myocytes (21 , respectively (n = 3 -5).
In another series of experiments, we investigated the possible contribution of P2Y receptors to the UTPinduced current by intracellularly applying the activator and inhibitor for trimeric G-protein-mediated signaling, guanosine 5′-O-3′-thiotriphosphate (GTPγS) and guanosine 5′-O-thiodiphosphate (GDPβS), respectively. Neither GTPγS nor GDPβS (1 mM each) affected the UTPinduced current (Fig. 3A) . We also examined the effects of P2X 1 -receptor antibody (1:200), which has been shown to functionally inhibit P2X 1 receptor in rabbit portal vein myocytes (22) . P2X 1 -receptor antibody applied from the patch pipette greatly suppressed the magnitude of cationic currents maximally activated by 1 mM UTP (Fig. 3A , P < 0.01 by one-way ANOVA). The inhibitory effect of the antibody was diminished when it was pre-incubated with the epitopic peptide before use. These results largely exclude the contribution of P2Y receptor / G-protein-mediated pathway, but strongly suggest the involvement of P2X 1 receptor in the generation of cationic currents by UTP.
TRP protein does not contribute to UTP-induced current in aortic myocyte
In previous studies with the anti-sense technique by the reverse permeabilization method, it was reported that in cerebral artery myocytes (10), UTP activates a TRPC3-like channel through P2Y receptors. However, we could not record a TRPC3-like outwardly rectifying, G-protein dependent current (11, 23 -26) (Figs. 1A, 3A , and Supplementary Fig. 3 ) from rat isolated aortic, cerebral, and mesenteric arterial myocytes. Furthermore, the functionally effective antibody for TRPC3 (27, 28) (Fig. 3B) and ethyl-1-(4-(2,3,3-trichloroacrylamide)phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate (pyrazole 3), a relatively specific inhibitor of TRPC3 (29), exerted little discernible effects on UTP-induced current (1 μM; 100.0 ± 1.5% of the control, n = 8). SKF-96365 and 2-aminoethyl diphenylborinate (2-APB), potent TRPC3 blockers, were also ineffective to inhibit the current (for 30 and 100 μM; 102.8 ± 4.6% and 100.3 ± 2.6% of the control, n = 5, respectively) (24, 25, 28, 30) . These results strongly negate the involvement of TRPC proteins and further corroborate our above conclusion that the molecular entity of UTP-induced current is a P2X (probably P2X 1 ) receptor-type cation channel. 
UTP-induced single channel activity
We further performed single channel recording in outside-out patch membranes. Whereas α,β-methylene ATP (10 μM) elicited typical P2X 1 receptor-like fast inactivating current, UTP (1 mM) evoked a sustained inward current at −60 mV (Fig. 4A) . The unitary conductance estimated by a ramp potential protocol (−160 to +40 mV; 1.5 s) was 10.5 ± 0.1 (n = 5) and 10.4 ± 0.1 pS (n = 5) for α,β-methylene ATP and UTP, respectively (Fig. 4B) .
The average of 30 ramp current traces disclosed an inward-rectifying current reversing near 0 mV, the properties being similar to those observed for macroscopic currents (Fig. 4C vs. Fig. 1Ab ).
These results further confirm that α,β-methylene ATP and UTP can activate an identical P2X-type receptor.
UTP contracts rat aortic smooth muscle
To observe the functional effects of UTP on intact arteries, we performed a tension recording with the rat aortic ring preparation denuded of endothelium to exclude the endothelium-dependent effects via P2 receptors (3). UTP elicited a biphasic contraction consisting of an initial fast twitch-like or "phasic" component and a subsequent sustained or "tonic" component in Krebs solution containing 2 mM Ca 2+ and tetrodotoxin (1 μM). The phasic contraction was first evident at a concentration as low as 10 μM and its magnitude was constant over a wide range of concentrations examined. It was similar to the purinergic component of the neurogenic contraction in rat mesenteric artery (31) . In contrast, the magnitude of the tonic contraction was increased concentration-dependently (1 μM -3 mM, Fig. 5A: a and b) . However, when we applied UTP cumulatively, the phasic contraction disappeared at 1 mM due presumably to desensitization (Fig. 5Aa) . A similar result was also observed in the UTP-induced currents by whole cell patch-clamp experiment ( Supplementary Fig. 3B ). These results suggest that UTP-induced contraction and current are activated by the same receptor.
In Ca
2+
-free solution, the phasic contraction was completely abolished, while the tonic contraction was only partially inhibited. Re-addition of external Ca 2+ (2 mM) restored both contractions (Fig. 5B) . Similar abolition of the phasic contraction and partial inhibition of the tonic contraction was observed with pre-applied nifedipine (10 μM), a specific blocker for L-type voltage-dependent calcium channels, or TNP-ATP (30 μM), the P2X-receptor antagonist (Fig. 5: C and D ; the effect of TNP-ATP on the phasic contraction is not shown). The effects of pre and post-applied nifedipine (10 μM) on tonic contraction was statistically different (35.8 ± 5.8% and 11.7 ± 1.7% inhibition, respectively; n = 6, P < 0.005) (Fig.  5C ). Therefore, we used pre-applied and high concentration of nifedipine (10 μM) and TNP-ATP (30 μM) for observing the maximum effect on contraction (see Figs. 2B and 5C). Inhibitory effects of pre-applied 0 mM Ca 2+ Krebs + 0.5 mM EGTA, nifedipine (10 μM), and TNP-ATP (30 μM) on tonic contraction were statistically different from control condition (2 mM Ca 2+ Krebs; P < 0.01). However, there were no significant differences among their inhibitory effects (Fig. 5D) . The remaining component of the UTP-induced tonic contraction in the absence of Ca 2+ (0 mM Ca 2+ + 0.5 mM EGTA) was almost completely inhibited by 5-min pretreatment with thapsigargin (TG) that depletes internal Ca 2+ stores (Fig.  5 : B and D, P < 0.001). Similar to UTP, unique patterns of both phasic and tonic contraction were also observed in response to α,β-methylene ATP ( Supplementary Fig. 4 : A, B: available in the online version only). However, in contrast to the partial inhibition of the UTP-induced contractions, the entire contractile response was almost completely suppressed by 0 mM Ca 2+ PSS + 0.5 mM EGTA, nifedipine (10 μM), and TNP-ATP (30 μM) ( Supplementary Fig. 4 : A, C; P < 0.001, compared to the control).
These results indicate that the phasic component of UTP-induced contraction of aortic muscle exclusively reflects Ca 2+ influx through L-type Ca 2+ channels that are presumably activated by membrane depolarization resulting from P2X 1 -like receptor activation. In contrast, the tonic component appears to depend on both voltagedependent Ca 2+ influx and intracellular Ca 2+ release, the latter being independent of P2X receptor and mediated presumably via activation of P2Y receptors similar to previous reports (32, 33) (also see below).
Intracellular Ca
2+ imaging In a final series of functional experiments, we investigated the impact of UTP on intracellular Ca 2+ dynamics in rat aortic myocytes by using digital Ca ; the mean value of the latency was 3.3 ± 0.1 (n = 186) and 13.5 ± 0.7 (n = 93) s for normal (2 mM Ca 2+ -containing) and Ca 2+ -free PSS, respectively (Fig.  6Ab) . These phenomena were also observed for UTP and ATP in pig aorta, rat pulmonary artery, and human umbilical cord smooth muscle cells (34 -36) . Averaging individual traces clearly indicated that the initial Ca ] i rise in each single myocyte showed the transient, but not oscillatory pattern (data not shown) (36) . This implies that the oscillatory change caused by P2Y mediated intracellular Ca 2+ release. These results suggest that UTP contracts intact aortic muscle through coincident activation of the P2X 1 receptor / L-type VDCC and P2Y receptor / Gprotein / PLC pathways, which lead to Ca 2+ influx and intracellular Ca 2+ release, respectively.
Distribution of P2 receptor subtypes in arteries
Finally, we surveyed the expression of P2X 1 receptor and TRPC3 proteins in rat cerebral and mesenteric arteries and aorta by using Western blotting. From all these tissues, abundant P2X 1 -receptor proteins were detected. In contrast, a faint or no expression (each 3 cases) of TRPC3 protein was observed in all arteries compared with rat brain extract (Fig. 7A) . Messenger RNA transcripts of both P2X 1 receptor and P2Y 2 , P2Y 4 , and P2Y 6 receptors were successfully amplified in cerebral and mesenteric arteries and aorta by the RT-PCR technique (Fig. 7B, Supplementary Fig. 5 : available in the online version only). Moreover, immunocytochemistry showed the localization of P2X 1 receptor on the plasma membrane of aortic smooth muscle cells, and the intensity was high enough compared to α-smooth muscle actin as a positive control, and some immunofluorescence appeared co-localize at the plasma membrane (Fig. 8: Aa,  B) (37) . The immunofluorescence by P2X 1 -receptor antibody had almost disappeared on pre-incubation with its antigen peptide (Fig. 8Ab) . On the contrary, immunofluorescence of TRPC3 was very low compared to P2X 1 receptors and the localization of TRPC3 was diffuse in the cytosol (Fig. 8Ac) .
For aorta slice staining, high expression of P2X 1 -receptor protein was observed in both the smooth muscle layer (arterial media: middle layer in Fig. 9A ) and the endothelial layer (intima: lower layer in Fig. 9A ). Preincubation of the antibody with the antigen peptide weakened the fluorescence observed in the cell layer; instead, a striped pattern (elastic lamina) between the smooth muscle layers, which are probably non-specific staining, became evident for unknown reason(s) (compare Fig. 9: A and B) , indicating the specific staining. An α-smooth muscle actin antibody with Alexa Fluor 488 specifically stained only smooth muscle in arterial media, but not intimal and adventitial layers. Under these conditions, immunofluorescent tissue staining for TRPC3 was low, similar to the result from immunocytochemistry described above (Figs. 8Ac, 9C ). Summarizing the above data, P2X 1 receptors were dominantly expressed in aortic smooth muscle cells. 
Discussion
The key findings of the present study can be recapitulated as follows: 1) UTP elicited a rapidly activating and desensitizing inward-rectifying cation current with pharmacological profiles consistent with those of P2X-receptor cation channel to the agonist and antagonists including α,β-methylene ATP, TNP-ATP, suramin, and PPADS; 2) the activation of the current by UTP was counteracted by a functional P2X 1 -dependent, and -independent pathways; 5) robust expressions of P2X 1 -receptor transcript and protein were detected in rat aorta, cerebral, and mesenteric arteries by RT-PCR, Western blotting, and immunohistochemical analyses.
Upon repetitive applications of UTP, evoked currents but not the contraction showed quick run-down phenomena (Fig. 5B, Supplementary Fig. 1 ). This might be due to preparations and methods used to record the currents (single myocytes) and tension developments (multi cellular arterial tissues). In the present study, we used the conventional whole-cell patch clamp method rather than the perforated patch clamp method, and it is well documented that the desensitization of P2X receptor and the sensitization (the run-down phenomenon) of L-type VDCC are controlled by cytosolic components including calmodulin, intracellular ATP, and unknown components (21, 38) . Therefore, it is reasonable to assume that the observed run-down of the UTP-induced currents in contrast to the tension development would be mainly due to the method (whole-cell patch clamp technique) and preparations.
In addition, Ca
2+
-free EGTA containing PSS evoked small but statistically significant decrease in the amplitude of the sustained component of the UTP-induced contraction without affecting the sustained increase in [Ca 2+ ] i (sustained Ca 2+ -transient). The precise reason for this discrepancy is unknown at present. However, this might be also due to the different preparations used (single myocytes and multi cellular arterial tissues). Furthermore, it should be mentioned that some myocytes showed an oscillatory Ca 2+ transient but others showed only a phasic one, and therefore the direct comparison between the sustained contraction and Ca 2+ transient might not be suitable.
It has long been believed that UTP is a specific P2Y receptor (P2Y 2 , P2Y 4 , and P2Y 6 ) agonist (3) and UTP depolarizes by activating the P2Y receptor-TRPC3 cascade (10) . Nevertheless, our present results strongly argue that in certain types of arteries, UTP can act as a P2X 1 -like receptor agonist to elicit biphasic contraction by opening nifedipine-sensitive VDCC in addition to eliciting intracellular calcium release via P2Y receptor (P2Y 2 , P2Y 4 , or P2Y 6 ) stimulation. Supportive evidence can be found in a previous study by McLaren et al. (32, 39) , in which UTP activated a P2X 1 -like receptor in rat tail artery smooth muscle cell and contracted via P2X 1 -like recep- tors and P2Y receptor(s) activation (32, 39) . Moreover, in mesenteric arterial smooth muscle, it was reported that activation of P2X 1 receptors by field stimulation of sympathetic nerves resulted in local, non-propagating junctional Ca 2+ transients (jCaTs) and concomitant phasic and tonic contractions (31) . These jCaTs and accompanying the decrease in vascular diameter completely disappeared by genomic knockout of P2X 1 receptor (40) . Furthermore, consistent with our data, TRPC3 proteins are rarely expressed in rat mesenteric artery myocytes (41) . In addition, the pharmacological profile of UTPinduced current is clearly different from that reported for expressed TRPC3 or its homologue TRPC6; IC 50 values for Gd 3+ and La 3+ to block UTP-induced current were similar to P2X 1 receptor expressed in Xenopus oocyte, but much higher than those reported for TRPC3 and TRPC6 (42 -46) .
Moreover, unitary conductance of UTP and α,β-methylene ATP-induced currents were both around 10 pS. These values were a little different to those from recombinant P2X 1 receptor (approximately 18 pS) (47), but quite different to those from TRPC3 (60 -66 pS), which showed non-inactivating activities evoked by ATP (100 μM) or carbachol (100 μM) (23, 24) . It is possible that the difference between the native P2X-like receptor evoked by UTP (about 10 pS) and recombinant P2X 1 receptor (about 18 pS) was due to contamination of the subconductance state, underestimation of channel conductances, or existence of hetero-oligomeric P2X receptors because of their diversity in arterial tissue (Supplementary Fig. 5) (21, 48) . These results also suggest that UTP activates the P2X receptor, but not TRPC3.
It has been reported that the P2X receptor-induced responses were lost by cell culture (49) . As a possible interpretation, tissue culture for permeabilization of the TRPC3 anti-sense DNA probe would abolish not only the expression of TRPC3 protein, but also the P2X-receptor response (10) . On the other hand, we previously reported that ATP can activate P2Y receptors (P2Y 1 and P2Y 11 -like) in small mesenteric arteries of guinea pigs, thereby regulating nifedipine-insensitive VDCCs positively and negatively via activation of G s / protein kinase A (PKA) and G q/11 / protein kinase C (PKC) pathways, respectively (50, 51) . Thus, it is reasonable to assume that dual activation of P2X (P2X 1 ) and P2Y receptors by ATP or UTP is a common mechanism to regulate the vascular tone, although the P2-receptor subtypes involved may vary with species and region of the vasculature.
In pathophysiological conditions such as hypoxia and inflammation, it is known that UTP and ATP are released from endothelial and smooth muscle cells (3, 52) . During the inflammation, cell swelling or tissue congestion may increase the cell membrane tension and/or interstitial pressure around the cells. This may also facilitate the release of UTP and mechanically sensitize the nearby P2X 1 and P2Y receptors. This would be more prominent during vascular injury where higher amounts of UTP and ATP released from damaged cells may affect local vascular tone via activation of P2X 1 and P2Y receptors. It has been estimated that the resting level of ATP in hypoxic cells would be maintained at more than 3 mM, which is about 20% -30% of normal conditions (53) . Simple calculation indicates that at least 300 μM of UTP (i.e., about 10% of ATP) could be released from damaged cells (52) , which would be sufficient to activate P2X 1 and P2Y receptors (Figs. 1, 2, and 5) .
UTP shows the dual responses of contraction and relaxation of vasculature as a direct effect on smooth muscle cells and an indirect effect via endothelial cells, respectively (18, 54) . During ischemia, vasculature shows acute relaxation, but this is chronically converted to the contraction phase in cerebral and pulmonary artery (55, 56) . The chronic effect is more important for vasospasm, which usually develops 4 and 12 days after subarachnoid hemorrhage (57) . Intriguingly, the rabbit middle cerebral artery injected with blood as a model of subarachnoid hemorrhage showed an unusually enhanced sensitivity to UTP; contraction to low concentrations of UTP (1 -3 μM) was evidently increased at 24 h (not 10 min) after the blood injection (58) . This chronic vascular hyper-reactivity has been implicated in the pathogenesis of cerebral vasospasm, which usually develops with subsequent elevation of intravascular pressure after subarachnoid hemorrhage (58) . These observations, in conjunction with the present results, suggest to us that UTP-mediated mechanisms have an abnormally enhanced vascular reactivity under pathophysiological conditions.
In conclusion, we found that extracellular UTP activates both P2X 1 and P2Y receptors, thereby eliciting biphasic vasoconstriction by promoting Ca 2+ influx via nifedipine-sensitive Ca 2+ channels and intracellular Ca 2+ release from sarcoplasmic reticulum (Fig. 10) . These findings may indicate a major pathophysiological role of UTP for abnormal vascular reactivity in ischemia, stroke, and subarachnoid hemorrhage, and thus the receptors for UTP in arteries (P2X 1 and P2Y) may be the targets of hypoxic and inflammatory vascular disorders and vascular injury.
